These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Automated urinalysis with expert review for incidental identification of atypical urothelial cells: An anticipated bladder carcinoma diagnosis. Anderlini R; Manieri G; Lucchi C; Raisi O; Soliera AR; Torricelli F; Varani M; Trenti T Clin Chim Acta; 2015 Dec; 451(Pt B):252-6. PubMed ID: 26460065 [TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536 [TBL] [Abstract][Full Text] [Related]
6. Does subdivision of the "atypical" urine cytology increase predictive accuracy for urothelial carcinoma? Bostwick DG; Hossain D Diagn Cytopathol; 2014 Dec; 42(12):1034-44. PubMed ID: 24838797 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634 [TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors. Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289 [TBL] [Abstract][Full Text] [Related]
9. The fate of an unsatisfactory urine cytology test among patients with urothelial carcinoma. Ordon M; Boerner S; Zlotta AR; Jewett MA; Fleshner N BJU Int; 2009 Dec; 104(11):1641-5. PubMed ID: 19583723 [TBL] [Abstract][Full Text] [Related]
11. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. Halling KC; King W; Sokolova IA; Karnes RJ; Meyer RG; Powell EL; Sebo TJ; Cheville JC; Clayton AC; Krajnik KL; Ebert TA; Nelson RE; Burkhardt HM; Ramakumar S; Stewart CS; Pankratz VS; Lieber MM; Blute ML; Zincke H; Seelig SA; Jenkins RB; O'Kane DJ J Urol; 2002 May; 167(5):2001-6. PubMed ID: 11956427 [TBL] [Abstract][Full Text] [Related]
12. Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens. Ylagan LR; Humphrey PA Acta Cytol; 2001; 45(4):599-604. PubMed ID: 11480725 [TBL] [Abstract][Full Text] [Related]
13. Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy? Bolenz C; West AM; Ortiz N; Kabbani W; Lotan Y Urol Oncol; 2013 Apr; 31(3):366-71. PubMed ID: 21414815 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of NMP22 as an adjunct to a typical urine cytology and low-grade urothelial carcinoma. Arora VK; Sarungbam J; Bhatia A; Singh N; Agrawal V; Aggarwal S Diagn Cytopathol; 2010 Nov; 38(11):788-90. PubMed ID: 20014314 [TBL] [Abstract][Full Text] [Related]
15. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses. Garbar C; Mascaux C; Wespes E Cytopathology; 2007 Apr; 18(2):79-83. PubMed ID: 17397491 [TBL] [Abstract][Full Text] [Related]
16. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review. Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052 [TBL] [Abstract][Full Text] [Related]
17. [Urinary cytology of transitional-cell carcinoma]. Piazza G; Galia A; Cosentino A; Grasso G Pathologica; 1995 Apr; 87(2):146-7. PubMed ID: 8532407 [TBL] [Abstract][Full Text] [Related]
18. [Clinical value of combined detection with urinary bladder cancer antigen, hyaluronic acid and cytokeratin 20 in diagnosis of bladder cancer]. Pu XY; Wang ZP; Chen YR; Wu YL; Wang HP; Wang XH Ai Zheng; 2008 Sep; 27(9):970-3. PubMed ID: 18799038 [TBL] [Abstract][Full Text] [Related]
19. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813 [TBL] [Abstract][Full Text] [Related]
20. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]